tirzepatide for the treatment of obstructive sleep apnea and obesity in Obesity-Related Apnea: Beyond Weight Loss Toward Disease Modification? Tirzepatide for the treatment of

This includes people with inner ear problems, migraines, or balance disorders

GLP-1 RAs and Their Possible Use for Addiction and Inflammatory Conditions

It is simply to create the space in which raising a concern feels normal rather than like a failure

usually most pronounced during dose escalation Diarrhea : Affects 12-17% of patients, typically mild to moderate in severity Vomiting : Reported in 6-10% of patients, more common at higher doses Constipation : Occurs in 6-11% of patients Abdominal pain and dyspepsia : Generally transient Decreased appetite : An expected pharmacological effect contributing to weight loss Other documented adverse effects include injection site reactions, hypoglycemia (when used with insulin or sulfonylureas), and less commonly, fatigue

Turn off the tv and go for a walk